Matrix metalloproteinase-2 and -9 expression in sinonasal inverted papilloma

Rhinology

Volumn 44, Issue 3, 2006, Pages 211-215

  Papon, Jean François ^a,b   Lechapt Zalcman, E ^b   Abina, M ^b   Abd al Samad, I ^a   Peynegre R ^a   Escudier, E ^b,c   Coste, A ^a,b  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Epithelium; Gelatinase; Inverted papilloma; Metalloproteinase; Nose

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INVERTED PAPILLOMA; LAMINA PROPRIA; NOSE MUCOSA; NOSE POLYP; PARANASAL SINUS TUMOR; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SNORING;

CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NASAL MUCOSA; NASAL POLYPS; NOSE NEOPLASMS; PAPILLOMA, INVERTED;

EID: 33749020556     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Batsakis JG. Pathology consultation. Nasal (Schneiderian) papillomas. Ann Otol Rhinol Laryngol 1981; 90: 190-191.
2. Lawson W, Kaufman MR, Biller HF. Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases. Laryngoscope 2003; 113: 1548-1556.
3. Califano J, Koch W, Sidransky D, Westra WH. Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma. Am J Pathol 2000; 156: 333-337.
4. Roh HJ, Procop GW, Batra PS, Citardi MJ, Lanza DC. Inflammation and the pathogenesis of inverted papilloma. Am J Rhinol 2004; 18: 65-74.
5. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999; 20: 1100-1102.
6. Collier IE, Wilhelm SM, Eisen AZ, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 6579-6587.
7. Lee KS, Jin SM, Kim HJ, Lee YC. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2003; 111: 1278-1284.
8. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448-464.
9. Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001; 193: 233-241.
10. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 273-282.
11. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-285.
12. Yao PM, Buhler JM, d'Ortho MP, et al. Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 1996; 271: 15580-15589.
13. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 1998; 78: 1495-1502.
14. Schmidt M, Grunsfelder P, Hoppe F. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma-correlations with growth factor expression in vivo? Eur Arch Otorhinolaryngol 2001; 258: 472-476.
15. Zheng L, Lam WK, Tipoe GL, et al. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur Respir J 2002; 20: 170-176.
16. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999; 159: 1298-1307.
17. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-744.
18. Guichard C, Gilain L, Abd-Al Samad I, et al. Epithelial cell proliferation, apoptosis, and apoptosis inhibition in inverted papillomas. Laryngoscope 1998; 108: 716-720.
19. Nagaoka I, Hirota S. Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs. Inflamm Res 2000; 49: 55-62.
20. Yokoshima K, Ohnishi M, Takizawa R, Pawankar R, Okubo K and Okuda M. [Cytokines of nasal inverted papilloma: quantification and distribution]. Nippon Jibiinkoka Gakkai Kaiho 1995; 98: 66-70.
21. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72: 391-398.
22. Festuccia C, Bologna M, Vicentini C, et al. Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int J Cancer 1996; 69: 386-393.
23. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 1996; 39: 1255-1264.